https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694455/

Published online 2017 Nov 14  \\ Pubertyblockers

Utdrag fra artikkelen:

Introduction: Gender dysphoria (GD) (DMS-5) is a condition marked by increasing psychological suffering that accompanies the incongruence between one's experienced or expressed gender and one's assigned gender. Manifestation of GD can be seen early on during childhood and adolescence. During this period, the development of undesirable sexual characteristics marks an acute suffering of being opposite to the sex of birth. Pubertal suppression with gonadotropin releasing hormone analogs (GnRHa) has been proposed for these individuals as a reversible treatment for postponing the pubertal development and attenuating psychological suffering. Recently, increased interest has been observed on the impact of this treatment on brain maturation, cognition and psychological performance.

Referenser

New Paper Says Puberty Blockers Aren’t the Answer to Gender Confusion

June 20, 2017  \\ Pubertyblockers

Utdrag fra artikkelen:

"Whereas 80 to 95 percent of children with gender dysphoria will come to identify with and embrace their biological sex, none of the children placed on puberty blockers in the Dutch clinic that pioneered this treatment came to identify with their biological sex. All of them persisted in their transgender identity."

Referenser